Sienna Biopharmaceuticals Appoints Finance Veteran, James M. Hindman, to Board of Directors
August 02, 2018 09:05 ET
|
Sienna Biopharmaceuticals, Inc.
-- Hindman will chair Sienna’s Audit Committee WESTLAKE VILLAGE, Calif., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (NASDAQ:SNNA), a clinical-stage medical dermatology and...